HOME >> BIOLOGY >> NEWS
Study begins to reveal clues to the cause and progression of sepsis

PITTSBURGH, Aug. 13 Not all patients with sepsis mount the same immune response, even when they look the same clinically, according to findings from the first large-scale natural history study of sepsis. The results, published by University of Pittsburgh School of Medicine researchers in the August 13/27 issue of the Archives of Internal Medicine, indicate that past interpretations of how the immune system responds to infection interpretations on which many experimental treatments were based were incorrect.

This year, nearly 1 million Americans will develop sepsis, a result of the bodys inflammatory response to an infection, which can lead to organ failure and death. More than 30 percent will die, making sepsis the 10th leading cause of death. While incidence rates of sepsis have been steadily increasing over the years, little is known about the condition. Past investigational treatments have been based on data from small studies, and most of these therapies have failed.

Researchers at the University of Pittsburgh believe that these treatments failed, at least in part, because of insufficient data to fully understand the complexity and variability of the inflammatory response to sepsis. To gain a better understanding into the mechanisms behind the condition, the researchers conducted the Genetic and Inflammatory Markers of Sepsis study (GenIMS), which collected extensive clinical and laboratory data geared to help analyze the risks of a person developing sepsis and dying. Data were collected from 2,320 subjects who came to hospital emergency rooms at 28 sites nationwide.

With sepsis, were dealing with one of the deadliest diseases, yet we know so little about the condition. The situation is similar to what this country experienced over 50 years ago with heart disease and stroke we knew that too many people were dying of cardiovascular disease, but we didnt know enough about the disease to effectively treat and prevent it, sa
'"/>

Contact: Jocelyn Uhl Duffy
UhlJH@upmc.edu
412-647-3555
University of Pittsburgh Schools of the Health Sciences
13-Aug-2007


Page: 1 2 3

Related biology news :

1. Study finds gender differences in renal and other genes contributing to blood pressure
2. Study suggests estrogen deficiency can lead to obesity-induced high blood pressure after menopause
3. Study: Sticking to the sand might not be such good, clean fun for beachgoers
4. Study points to new way to predict death risk from torn aorta
5. Study identifies new gene therapy tools for inherited blindness
6. Study finds contaminated water reaching Floridas offshore keys
7. Study sheds light on why humans walk on two legs
8. Study explains how pathogens evolve to escape detection
9. Study finds hereditary link to premenstrual depression
10. Study identifies energy efficiency as reason for evolution of upright walking
11. Study shows cane sugar, corn sweeteners have similar effects on appetite

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/10/2020)... ... 10, 2020 , ... Cytonus Therapeutics Inc. today announced that ... Vice President of Strategic Initiatives, Portfolio Innovation and Investor Relations at Allergan, plc. ... are extremely pleased to welcome Manisha Narasimhan as an independent director," commented Christopher ...
(Date:3/5/2020)... ... 05, 2020 , ... Patients in need of new teeth after tooth extraction ... of Dental Implants of Ocala. Same-day dental implants allow patients with an ... just one day. This treatment utilizes advanced technology and Dr. Brand’s unique experience and ...
(Date:3/4/2020)... ... March 04, 2020 , ... The ... apply to the MedTech IGNITE program’s 2020 IGNITE Cohort. The MedTech IGNITE Program ... attract and nurture the next generation of medtech founders and entrepreneurs. IGNITE Cohort ...
Breaking Biology News(10 mins):
(Date:3/10/2020)... ... ... Ortho Clinical Diagnostics, a global leader of in vitro diagnostics dedicated to improving ... of extended antigen in a gel testing format used for blood phenotyping for patients ... Max in the United States and Canada. The clearances allow testing for more than ...
(Date:3/4/2020)... ... ... This month, Cognosante will make its annual appearance at the HIMSS Global ... emerging offerings that align with the HIMSS annual theme, “Be the Change.” , ... engaging. From Interoperability and HIE to Cloud Computing and ...
(Date:2/28/2020)... ... February 26, 2020 , ... ... a high-speed camera with a dedicated controller, thus simplifying setup, streamlining integration, and ... HS7 is the first of Fastec Imaging’s new HS Series cameras to be ...
(Date:2/21/2020)... ... 20, 2020 , ... The dietary supplement industry now has ... listed on an ingredient panel is actually in their product. As a ... adoption of CertainT, which is designed to protect the intellectual property (IP) of ...
Breaking Biology Technology:
Cached News: